1800013I battelle memorial institute; immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against BSL-4 pathogens in nhps; to 2 base award; biod can…

Active Awarded Last action

Contract number
75N93019F00131
Awardee
Awarding agency
Obligated
$11,516,755

Award facts

Contract value 56% obligated
  • $11,516,755.47 Current, with exercised options
  • $20,568,232.47 Potential, with all options
Completion date 82% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 -$215,986
Exercise an Option P00012 $2,404,344
Supplemental Agreement for work within scope P00011 $0
Exercise an Option P00010 $2,688,967
Funding Only Action P00009 -$1,086,171
Supplemental Agreement for work within scope P00008 $0
Exercise an Option P00007 $2,467,841
Exercise an Option P00006 $134,146
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $488,832
Exercise an Option P00003 $2,017,558
Exercise an Option P00002 $2,000,267
Supplemental Agreement for work within scope P00001 · Battelle memorial institute; immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against BSL-4 pathogens in nhps; to 2 $0
Original award $616,957
Show all 14

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases issued a delivery order to Battelle Memorial Institute on July 30, 2019, with a ceiling value of $20.568 million for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against BSL-4 pathogens in nonhuman primates.

This order is issued under the Pre-Clinical Models of Infectious Diseases IDC, Battelle's $146.3 million NIAID contract (July 2024–July 2031) supporting preclinical drug candidate evaluation and vaccine testing. Place of performance is Columbus, OH. The order's ultimate completion date is May 31, 2028. Work is priced cost-plus-fixed-fee with no set-aside.

Service Contract Inventory data shows the order deployed 0.4 FTEs and 783 contractor hours in fiscal year 2025, with a derived government-paid rate of $438.53 per hour. Subcontractors performed 75 percent of contractor hours in FY2025. Labor footprint declined substantially year-over-year: FY2021 recorded 2.3 FTEs and 4,877 contractor hours at $389.87 per hour, while FY2023 peaked at 1.6 million invoiced with 1.4 FTEs and 2,892 contractor hours at $558.33 per hour before tapering through FY2025.

Description

As the agency reported it.

1800013I battelle memorial institute; immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against BSL-4 pathogens in nhps; to 2 base award; biod can 8470038; $616,957

Quick answers

Who was awarded contract 75N93019F00131?

75N93019F00131 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 30, 2019.

How much is contract 75N93019F00131 worth?

The government has obligated $11,516,755 on 75N93019F00131. Its potential value, with all options, is $20,568,232.

Is contract 75N93019F00131 an order under another contract?

Yes. 75N93019F00131 is a delivery order under 75N93018D00013, an indefinite delivery contract.

Was contract 75N93019F00131 competed?

The extent of competition for 75N93019F00131 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login